IP Library Granted Patent US 12,442,032
Granted Patent B2
US 12,442,032 · App. 17/237,518 · Granted Oct 14, 2025

Solid support for sample collection

Inventors: Peter James Tatnell (Cardiff, GB); Nina Moran (Bristol, GB)
Assignee: Global Life Sciences Solutions Operations UK Ltd
C12Q1/6806G01N1/02G01N1/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,442,032
App. No.
17/237,518
Granted
Oct 14, 2025
Kind
B2
Abstract

The present invention relates to means for collection of biological samples. Specifically, the present invention provides a solid support for collection, storage and subsequent analysis of a biological sample as well as methods for use of the solid support of the invention and a kit comprising the solid support of the invention.

Claims (20)

1. A method for collecting a biological sample comprising, applying a biological sample to a solid support, wherein said sample support comprises:

a dye selected from the group consisting of Alizarin Red, Methylene blue, Reactive blue 4, Alcian blue, and Indigo carmine;

Tris HCl;

Tris EDTA;

SDS; and

uric acid;

wherein when the dye is Alizarin Red, the Alizarin Red is used at a concentration of about 0.3 to about 3.9 mM,

wherein when the dye is Methylene blue, the Methylene blue is used at a concentration of about 0.3 to about 4.0 mM,

wherein when the dye is Reactive blue 4, the Reactive blue 4 is used at a concentration of about 0.31 to about 3.14 mM,

wherein when the dye is Alcian blue, the Alcian blue is used at a concentration of about 0.1 to about 5 mM,

wherein when the dye is Indigo carmine, the Indigo carmine is used at a concentration of about 0.2 to about 7.5 mM,

wherein the solid support is configured to collect a biological sample,

wherein the solid support comprises a cellulose-based paper that is coated or impregnated with the Tris HCl, the Tris EDTA, the SDS, and the uric acid, and

wherein the dye is resistant to one or more of colour changes or colour fading, when exposed to one or more of ethylene oxide or ultra violet radiation.

2. The method of claim 1 , wherein said solid support is chemically impregnated with said dye.

3. The solid support as defined in claim 1 , wherein the dye is a first dye, and wherein said solid support further comprises a second dye selected from the group.

4. The method of claim 3 , wherein the first dye and the second dye are selected from Alizarin Red and Alcian blue; or Alizarin Red and Indigo Carmine; or Alcian blue and Indigo Carmine.

5. The method of claim 1 , wherein said solid support further comprises a chaotrope.

6. The method of claim 5 , wherein said chaotrope is a guanidinium salt.

7. The method of claim 1 , wherein said biological sample comprises a nucleic acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 056036/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2021
From: TATNELL, PETER JAMES; MORAN, NINA
To: GE HEALTHCARE UK LIMITED
Reel/Frame 056008/0363 →
Priority Claims (1)
GB 1603459 · Feb 29, 2016 · national
Continuity (2)
Division 16078787
Related Publication 20210238656A1 · Aug 5, 2021
References Cited (25)
US 3485587A · Keston · 1969 [cited by applicant]
US 6316248B1 · Elliott · 2001 [cited by examiner]
US 7261857B2 · Suslick · 2007 [cited by examiner]
US 7498133B2 · Fomovskaia et al. · 2009 [cited by applicant]
US 7563621B2 · Profitt · 2009 [cited by examiner]
US 9265856B2 · Song et al. · 2016 [cited by applicant]
US 20060154234A1 · Winther · 2006 [cited by examiner]
US 20140370513A1 · Ogden · 2014 [cited by examiner]
US 20160022853A1 · Hajime · 2016 [cited by examiner]
US 20160187309A1 · Kang · 2016 [cited by examiner]
US 20160327491A1 · Wood · 2016 [cited by examiner]
EP 0734684A1 · 1996 [cited by applicant]
EP 2410063A1 · 2012 [cited by applicant]
GB 888039A · 1962 [cited by applicant]
GB 2084725A · 1982 [cited by examiner]
WO WO0014505A1 · 2000 [cited by examiner]
WO WO0015776A1 · 2000 [cited by examiner]
WO WO0110471A1 · 2001 [cited by examiner]
Wikipedia, chaotropic agent, https://en.wikipedia.org/wiki/Chaotropic_agent, accessed May 30, 2023. [cited by examiner]
PCT International Search Report and Written Opinion for PCT Application No. PCT/EP2017/054636 mailed May 22, 2017 (9 pages). [cited by applicant]
GB Search Report for GB Application No. 11603459.7 mailed Nov. 28, 2016 (4 pages). [cited by applicant]
Stratagene (Gene Characteristics Kits), 1988. [cited by applicant]
Weiner et al., “Kits and Their Unique Role In Molecular Biology: A Brief Retrospective,” BioTechniques, 2008, 44:701-704. [cited by applicant]
EP Office Action Application No. 282904-EP-3 mailed Apr. 12, 2021 (86 pages). [cited by applicant]
Haines et al., Effect of Nucleic Acid Binding Dyes on DNA Extraction, Amplication and STR Typing, dated Jul. 15, 2015, published in Electrophoresis 2015, 36, (pp. 2561-2568). [cited by applicant]